EUVIMEDEUVIMED entdecken
Crossref

Assessment of Squamous Cell Carcinoma Antigen (SCCA) as a Predictive Tumor Marker in Oral Cavity Squamous Cell Carcinoma (SCC) Patients Following Definitive Surgery

Mausumi Iqbal, Mezbah Ul Azeez, A. K. M. Shafiul Kadir, Ariful Haque, Mohammad Ullah Shemanto, Asheque Rahman

International Journal of Innovative Science and Research Technology · 27.05.2026 · 1738

DOI: 10.38124/ijisrt/26may963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 27.05.2026. Verfasst von Mausumi Iqbal und 5 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Squamous cell carcinoma antigen (SCCA) plays a pivotal role as a biomarker in various squamous cell carcinomas. This investigation delves into the potential of serum SCCA levels as a predictive tumor indicator in patients with oral squamous cell carcinoma (OSCC) undergoing definitive surgery. The research was carried out at a tertiary oral care center in Dhaka, Bangladesh, involving a cohort of 30 OSCC patients. The primary objectives were to evaluate the correlation between elevated serum SCCA levels and advanced-stage and poorly differentiated OSCC, as well as to assess SCCA's utility as a biomarker for early recurrence detection. The study, which transpired between July 2012 and June 2013, employed a cross-sectional analytical in vitro design. Preoperative and postoperative (within one week and three months) serum samples were collected from each patient to assess SCCA levels. The results demonstrated a compelling association between higher preoperative serum SCCA levels and advanced-stage, poorly differentiated OSCC. Among the 30 patients, three experienced disease recurrence, all of whom initially presented elevated SCCA levels, which subsequently normalized post-treatment, only to rise again within three months. In summary, the potential of serum SCCA levels as a valuable biomarker for identifying OSCC and assessing patient prognosis post curative surgery is evident. Utilizing SCCA levels alongside other diagnostic methods can augment early recurrence detection, ultimately contributing to improved patient outcomes.

Zitieren

APA

Iqbal, M., Azeez, M. U., Kadir, A. K. M. S., Haque, A., Shemanto, M. U., & Rahman, A. (2026). Assessment of Squamous Cell Carcinoma Antigen (SCCA) as a Predictive Tumor Marker in Oral Cavity Squamous Cell Carcinoma (SCC) Patients Following Definitive Surgery. International Journal of Innovative Science and Research Technology, 1738. https://doi.org/10.38124/ijisrt/26may963

Vancouver

Iqbal M, Azeez MU, Kadir AKMS, Haque A, Shemanto MU, Rahman A. Assessment of Squamous Cell Carcinoma Antigen (SCCA) as a Predictive Tumor Marker in Oral Cavity Squamous Cell Carcinoma (SCC) Patients Following Definitive Surgery. International Journal of Innovative Science and Research Technology. 2026:1738. doi:10.38124/ijisrt/26may963

BibTeX
@article{Iqbal2026,
  author = {Iqbal, Mausumi and Azeez, Mezbah Ul and Kadir, A. K. M. Shafiul and Haque, Ariful and Shemanto, Mohammad Ullah and Rahman, Asheque},
  title = {Assessment of Squamous Cell Carcinoma Antigen (SCCA) as a Predictive Tumor Marker in Oral Cavity Squamous Cell Carcinoma (SCC) Patients Following Definitive Surgery},
  journal = {International Journal of Innovative Science and Research Technology},
  year = {2026},
  pages = {1738},
  doi = {10.38124/ijisrt/26may963}
}
Kostenlos starten →